Atlas Trials

German CLL Study Group

37 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch German CLL Study Group

RecordFirmDate
A Prospective Observational Trial to Assess Treatment Sequences and Factors That Impact Overall Sur-vival in Patients With Chronic Lymphocytic Leukaemia (CLL) Treated Within First-line Studies of the GCLLSG (NCT06792994)German CLL Study Group2026-04-02
A Phase-3-trial of Acalabrutinib, Obinutuzumab & Venetoclax Compared to Obinutuzumab and Venetoclax in Previously Untreated Patients With High Risk CLL (NCT05197192)German CLL Study Group2022-04-19
Efficacy of Acalabrutinib in Very Old or Frail Patients With Treatment-naïve or Relapsed/Refractory CLL (NCT04883749)German CLL Study Group2021-06-01
Ibrutinib Monotherapy Versus Fixed-duration Venetoclax Plus Obinutuzumab Versus Fixed-duration Ibrutinib Plus Venetoclax in Patients With Previously Untreated Chronic Lymphocytic Leukaemia (CLL) (NCT04608318)German CLL Study Group2021-03-01
Efficacy and Safety of Zanubrutinib Plus Tislelizumab Treatment with or Without Sonrotoclax for Patients with Richter Transformation (NCT04271956)German CLL Study Group2020-02-19
Sequential Regimen of Bendamustin-Debulking Followed by Obinutuzumab, Acalabrutinib and Venetoclax in Patients With Relapsed/Refractory CLL (NCT03787264)German CLL Study Group2019-01-14
Obinutuzumab Containing Conditioning Regimen for Patients With Poor Risk CLL or Richter's Transformation Requiring Allogeneic Stem Cell Transplantation (NCT03153514)German CLL Study Group2017-11-13

Track German CLL Study Group automatically

Every clearance here is in the API, with alerts when new ones post.